Table: begin end state 1 29 cytoplasmic 30 48 transmembrane 49 60 non-cytoplasmic 61 80 transmembrane 81 94 cytoplasmic 95 114 transmembrane 115 120 non-cytoplasmic 121 142 transmembrane 143 153 cytoplasmic 154 177 transmembrane 178 187 non-cytoplasmic 188 209 transmembrane 210 256 cytoplasmic 257 278 transmembrane 279 297 non-cytoplasmic 298 316 transmembrane 317 322 cytoplasmic 323 339 transmembrane 340 344 non-cytoplasmic 345 366 transmembrane 367 376 cytoplasmic 377 400 transmembrane 401 412 non-cytoplasmic 413 431 transmembrane 432 471 cytoplasmic
Input: >AO356_25010 FitnessBrowser__pseudo5_N2C3_1:AO356_25010 MIGRHPLNNVTDSTHDSTLALAAAKVKRHVLPLVVVMFIVNYIDRVNIGFVRSHLETDLG IGAAAYGLGAGLFFVGYALFEVPSNMLLQRYGARAWLTRIMFTWGAAAMAMAFVQGETSF YVLRFILGAAEAGFFPGIIYYFTQWLPANERGKAMAIFLSGSAIASVISGPVSGALLHIS GMGLHGWQWMFLIEGFASIVLCGFVWFWLQSHPSQAKWLTAEEKAVLIAAIAEEQRAREA AQVIKPSMFKLLADRQIALFCFIYFSIALTIYGATFWLPSMIKKMGGLGDFQVGLLNSIP WIISIVAMYGFAALAGKWKFQQAWVAVTLVIAAFGMFMSTTGGPIFAFVAICFAAIGFKA ASALFWPIPQSYLDARVAAAVIALINSIGNLGGFVAPTAFGFLEQTTGSIEGGLYGLAAT SLVAAVVIFFARTAPKRDTPNSLSGRPETVAEANQLEKSQALKPGPSGAAV
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server